Finance

Lists
ENOV:NYSE
Enovis Corp
USD 18,05
-1,20%
(-0,22) 1D
USD 18,05
0,00% (0,00)
After hours
Closed: 1 Okt., 16:00:03 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENOV...
Open
USD 18,19
High
USD 18,51
Low
USD 17,74
Mkt. cap
1,04 mjd
Avg. vol.
1,75 m
Volume
0,00
52-wk high
USD 34,28
52-wk low
USD 17,30
EPS
-USD 19,27
Beta
1,10
Shares outstanding
57,67 m
No. of employees
8 k
Open
USD 18,19
High
USD 18,51
Low
USD 17,74
Mkt. cap
1,04 mjd
Avg. vol.
1,75 m
Volume
0,00
52-wk high
USD 34,28
52-wk low
USD 17,30
EPS
-USD 19,27
Beta
1,10
Shares outstanding
57,67 m
No. of employees
8 k
News stories
From web sources and news partners
Investing.com Canada
Investing.com Canada
·
1 uur gelede
Form 4 Enovis Corp For: 1 October By Investing.com
Profile
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Dallas, Texas and is listed on the NYSE as ENOV. The company has over 8,000 employees operating at 30 sites around the world. Wikipedia
About Enovis Corp
CEOMatthew L. Trerotola
Employees7,8 k
Founded1995
HeadquartersWilmington, Delaware, Verenigde State van Amerika
SectorMedical device
Websiteenovis.com
Analyst ratings
Based on 12 analysts giving stock ratings to ENOV in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ENOV in the last 3 months.
Highest
Current USD 18,05
USD 52,00 (+188,09%)
Average
USD 38,82 (+115,07%)
Lowest
USD 27,00 (+49,58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Larry Biegelsen
Wells Fargo
Buy
Maintained
USD 33,00
+82,8%
09/08/2026
Caitlin Cronin
Canaccord Genuity
Buy
Reiterated
USD 45,00
+149,3%
09/01/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
USD 45,00
+149,3%
09/01/2026
David Turkaly
Citizens JMP
Buy
Maintained
USD 47,00
+160,4%
09/02/2026
Michael Matson
Needham
Buy
Maintained
USD 52,00
+188,1%
09/01/2026
Ryan Zimmerman
BTIG
Buy
Maintained
USD 36,00
+99,4%
09/01/2026
Vik Chopra
BMO Capital
Buy
Reiterated
USD 27,00
+49,6%
09/01/2026
Keith Hinton
Freedom Capital Markets
Buy
Maintained
USD 36,00
+99,4%
09/01/2026
Steven Lichtman
William Blair
Buy
Maintained
-
-
08/14/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
USD 28,00
+55,1%
08/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
USD 32,00
+77,3%
08/07/2026
Patrick Wood
UBS
Buy
Initiated
USD 51,00
+182,5%
07/28/2026
Rong Li
Jefferies
Buy
Reiterated
USD 40,00
+121,6%
07/14/2026
Unknown Analyst
Jefferies
Buy
Reiterated
USD 40,00
+121,6%
07/14/2026
Unknown Analyst
BMO Capital
Buy
Initiated
USD 29,00
+60,7%
07/09/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
USD 37,00
+105%
05/08/2026
Last report
06 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 0,90 / USD 0,85
+6,34%beat
Revenue / Est. (USD)
582,78 m / 581,84 m
+0,16%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Okt. 2025
Des. 2025
Apr. 2026
Jul. 2026
Revenue
548,91 m
575,76 m
589,15 m
582,78 m
Cost of goods sold
218,50 m
222,69 m
223,67 m
223,53 m
Cost of revenue
218,50 m
222,69 m
223,67 m
223,53 m
Research and development expenses
29,74 m
31,36 m
31,53 m
31,69 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245,42 m
249,84 m
270,58 m
261,61 m
Operating expense
318,85 m
326,38 m
344,02 m
334,86 m
Total operating expenses
537,35 m
549,08 m
567,69 m
558,39 m
Operating income
11,56 m
26,68 m
21,46 m
24,39 m
Other non operating income
448,00 k
1,93 m
3,27 m
-1,91 m
EBT including unusual items
-566,87 m
-509,55 m
634,00 k
7,46 m
EBT excluding unusual items
3,18 m
21,10 m
15,57 m
14,44 m
Income tax expense
4,00 m
9,26 m
9,04 m
8,50 m
Effective tax rate
-0,71%
-1,82%
1 426,66%
113,88%
Other operating expenses
-
-
-
-
Net income
-571,15 m
-520,59 m
-8,76 m
-1,19 m
Net profit margin
-104,05%
-90,42%
-1,49%
-0,20%
Earnings per share
0,75
0,95
0,89
0,90
Interest and investment income
12,00 m
12,60 m
10,00 m
10,50 m
Interest expense
-20,83 m
-20,11 m
-19,17 m
-18,54 m
Net interest expenses
-8,83 m
-7,51 m
-9,17 m
-8,04 m
Depreciation and amortization charges
-
-
-
-
EBITDA
85,94 m
103,69 m
94,82 m
95,42 m
Gain or loss from assets sale
281,00 k
329,00 k
-75,00 k
843,00 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme